Cutaneous Oncology News

A significant proportion of nonmelanoma skin cancer cases referred for Mohs micrographic surgery showed histologic features of aggressive cancers that were not apparent on the initial biopsy, according to research in Journal of the American Academy of Dermatology.

When discussing the risk for all skin cancers, it is important to consider family history of melanoma in a first-degree relative, according to Erin X. Wei, MD, staff physician at Brigham and Women’s Hospital and instructor of dermatology at Harvard Medical School, and colleagues in the most popular Healio Dermatology story last week.

Those with a family history of melanoma had a 74% increased risk for melanoma, according to a study that followed white participants for more than 20 years.

A new two-dimensional feature called calculated tumor area appears to have effective independent prognostic value in patients with melanoma, according to a retrospective cohort study published in JAMA Dermatology.

Patients with multiple primary melanoma tumors demonstrated significantly worse overall survival compared with patients with one primary tumor despite a significant decrease in Breslow thickness between the first and second tumors, according to results of a retrospective study published in JAMA Dermatology.

Skin Cancer in America 2019, a survey from Health Union, showed that a variety of risk factors, such as anxiety, and lower quality of life are linked to skin cancer recurrences.

CHICAGO — Michael R. Migden, MD, associate professor of dermatology and associate professor of head and neck surgery at The University of Texas MD Anderson Cancer Center, spoke with HemOnc Today at ASCO Annual Meeting about cemiplimab.

Melanoma detection and diagnoses with computer-aided systems showed similar sensitivities when compared with those from dermatologists; however, the real-world applicability of the technology is unknown, according to meta-analysis results published in JAMA Dermatology.

Twelve-month data from a large U.S. registry study confirmed the clinical utility and high negative predicative value of a pigmented lesion assay as a diagnostic tool in melanoma, according to research in Dermatology Online Journal.

“The possibility of being able to educate patients with something ‘concrete’ that they can see and touch could be a great addition to patient education,” Noelani González, MD, clinical instructor of dermatology at Mount Sinai Hospital, told Healio Dermatology regarding a recent popular story on research using a 3D-printed model before Mohs micrographic surgery.